New diagnostic pathway T2DM MCN professional conference 30/3/17

Slides:



Advertisements
Similar presentations
Produced by The Alfred Workforce Development Team on behalf of DHS Public Health - Diabetes Prevention and Management Initiative June 2005 Diabetes Prevention.
Advertisements

Glucose Tolerance Test Diabetes Mellitus Dr. David Gee FCSN Nutrition Assessment Laboratory.
Gestational diabetes mellitus (GDM), a common medical complication of pregnancy, is defined as “any degree of glucose intolerance with onset or first.
Screening and Eligibility for DPP Clinical Guidelines.
Diagnosis of Type 2 Diabetes 1. Diagnostic Criteria for Prediabetes and Diabetes in Nonpregnant Adults 2 NormalHigh Risk for DiabetesDiabetes FPG
HbA1c as a compass- pointing you to the right diagnosis? Eric S. Kilpatrick Department of Clinical Biochemistry Hull Royal Infirmary/Hull York Medical.
Hba1c for diagnosis Dr Karen Adamson. β-chain α-chain Glucose bound to N-terminal valine of β-chain.
Chronic kidney disease Mr James Hollinshead Public Health Analyst East Midlands Public Health Observatory (EMPHO) UK Renal Registry 2011 Annual Audit Meeting.
Screening and Eligibility for DPP Clinical Guidelines Presentation: Screening & Eligibility Klamath Tribe.
O Identify whether all patients in the practice population diagnosed with IFG have had a repeat fasting blood glucose (FBG) within the past 12months o.
Type 2 Diabetes- Treatment Toolbox by: Karen L. Staples, FNP, ACNP Where Do I Start?
Controversy: HbA1c vs blood glucose: what is the best option to diagnose Diabetes? Davide Carvalho Department of Endocrinology, Diabetes and Metabolism.
Diagnosis of diabetes. Diabetic symptoms Diabetic symptoms + venous sample for : –Random venous ≥ 11.1 mmol/l ( ) –Fasting glucose > 7(
Update on Diabetes Services 41 st Annual General Practitioner Study Day 28 th January 2012 Dr. Eoin O’Sullivan Consultant Endocrinologist Bon Secours Cork.
HEFT - Good Hope Gestational diabetes service. HEFT – Good Hope, Birmingham Heartlands and Solihull Hospitals Two very different patient populations >12000.
Diabetes National Diabetes Control Programme
Pre-diabetes: Risk Factors & Diagnosis Saoirse Ní Chuirrín DNS Caitriona Lordan Dietitian September 2015.
Source:
Diabetes Mellitus Introduction to Diabetes Epidemiology.
Is it possible to predict New Onset Diabetes After Transplantation (NODAT) in renal recipients using epidemiological data alone? Background NODAT is an.
A two stage screening process – the pre-diabetes pathway.
DIABETES CASE PRESENTATIONS 1 st - diagnosis. Case 1 Male, 24 yrs old Male, 24 yrs old Presents in the ER for nausea, vomiting, abdominal pain, shortness.
Screening System for Hypertension and Diabetes at Primary Care Level
The Use of Faecal Calprotectin in Primary Care
N323: Parent-Child Nursing
Diabetes Learning Event 7th October 2016
CHANGES in ada 2015.
Management of Diabetes in the Older Person
Prevention Diabetes.
New diagnostic pathway T2DM MCN professional conference 30/3/17
How did the audit come about?
DIP, GDM; CLINICAL IMPORTANCE AND NEW WHO DIAGNOSTIC CRITERIA FOR GDM
Screening for Diabetes in Pregnancy
New diabetes diagnosis pathway PLIG, 19th Jan 2017
NDA – THE LATEST DATA Prof Roger Gadsby MBE FRCGP Honorary Associate Clinical Professor , WMS GP Clinical Lead National Diabetes Audit.
Diabetes- pregnancy, labour and the puerperium guideline
Estimation of blood glucose in diabetes mellitus
Inpatient Laboratory Testing: To A1c or Not to A1c
A Study on Gestational Diabetes in Eastern India
Whole Blood Vs. Plasma Glucose Levels
Oral glucose tolerance test (GTT)
Asymptomatic Abnormal LFTs NHS Lothian guideline
PSO – Paper Switch Off Project
Dietary treatment in gestational diabetes: Relation to birth weight
Capacity Building for Prevention of Complication from Gestational Diabetes in Public health system, UP Dr Rajesh Jain Project Manager Diabetes Prevention.
Thursday 1st February pm – 5pm
Cardiometabolic Health Check
Management of Diabetes in the Older Person
Repeat fasting lipid profile to confirm in 1-2 weeks
Nutrition & Dietetic Service to Patients with Diabetes in West Berkshire Carolyn Jones Dietetic Team Lead.
Prediabetes Screening and Monitoring
Screening for Diabetes in Pregnancy
Monitoring in Type 2 Diabetes
Prevention Diabetes Dr Abir Youssef 29/11/2018.
Accepted 2 June Ryan Chen
دیابت سالمندان دکتر میترا مرادی نیا.
Primary Care Diabetes Dr Bruce Davies 02/01/2019
New diabetes diagnosis pathway PLIG, 19th Jan 2017
The Use of Faecal Calprotectin in Primary Care
NHS South Tees CCG Rapid Specialist Opinion (RSO)
Asymptomatic Abnormal LFTs NHS Lothian guideline
Hba1c for diagnosis Dr Karen Adamson.
Diabetes Mellitus in Primary Care
Calculate Well’s score for PE (BOX1)
Diabetes and Pregnancy
Consultant Clinical Biochemist
Remission of Type 2 diabetes
PowerPoint 16:9 Screen Ratio Template *
Schematic depiction of three stages of the natural history of T2D, noting several opportunities for improvement of management. Schematic depiction of three.
Presentation transcript:

New diagnostic pathway T2DM MCN professional conference 30/3/17 Nicola Zammitt CD – Edinburgh Centre for Endocrinology and Diabetes Secondary Care Clinical Lead Lothian Diabetes MCN Slides courtesy of Jonathan Malo (StR, Clinical Biochemistry)

HbA1c 67,994 Glucose 194,518 2016 primary care: New local pathway: Diagnosis of Diabetes in Asymptomatic adults Piloted in 2015 in SE Edinburgh GP practices Lothian-wide implementation from Oct 2016… Incorporates HbA1c in recognition of: expert consensus on use of HbA1c for diagnosis principal means for guiding diabetes management relative ease / convenience compared to fasting glucose, or OGTT However… glucose remains 1st line test: HbA1c £4.00 Glucose £0.70 number of primary care requests imply an unacceptable increase in cost & workload from switching to HbA1c as 1st line test 2016 primary care: HbA1c 67,994 Glucose 194,518

Diabetic Medicine 29,1350-1357 (2012)

Diagnosis of diabetes mellitus in ASYMPTOMATIC adults (If elderly, frail and asymptomatic, please consider whether screening is appropriate.) random glucose ≥11.1 mmol/L fasting glucose INITIAL lab glucose ≥7.0 mmol/L (random OR fasting) 7.8 – 11.0 mmol/L 6.1 – 6.9 mmol/L random glucose fasting

Determine whether at risk / diabetic Diagnosis of diabetes mellitus in ASYMPTOMATIC adults (If elderly, frail and asymptomatic, please consider whether screening is appropriate.) Take together on separate day Determine whether at risk / diabetic (see fasting glucose & HbA1C ranges below) random glucose ≥11.1 mmol/L fasting glucose & HbA1C fasting glucose INITIAL lab glucose ≥7.0 mmol/L (Omit HbA1C if not suitable. See below.*) (random OR fasting) 7.8 – 11.0 mmol/L 6.1 – 6.9 mmol/L random glucose fasting

Determine whether at risk / diabetic Diagnosis of diabetes mellitus in ASYMPTOMATIC adults (If elderly, frail and asymptomatic, please consider whether screening is appropriate.) Take together on separate day Determine whether at risk / diabetic (see fasting glucose & HbA1C ranges below) random glucose ≥11.1 mmol/L fasting glucose & HbA1C fasting glucose INITIAL lab glucose ≥7.0 mmol/L (Omit HbA1C if not suitable. See below.*) (random OR fasting) 7.8 – 11.0 mmol/L 6.1 – 6.9 mmol/L random glucose fasting * Not suitable for HbA1C 1) Rapid onset of diabetes a. Suspected T1DM – see symptomatic patient flowchart b. Drug-induced: steroids, anti-psychotics, immuno-suppressants – a fasting glucose may not be sufficient. c.Pancreatic disease 2) Conditions affecting Hb turnover / HbA1C assay a. Haemoglobinopathy b. Anaemia (especially haemolytic) c. Severe blood loss, Blood transfusion d. Splenomegaly / Splenectomy e. Renal dialysis +/- erythropoitein f. Anti-retrovirals, ribavarin, dapsone 3) Children Seek diabetes team advice * Pregnancy - see local guidelines for screening/referral a. HbA1C may be used to screen for pre-existing diabetes, but should NOT be used to screen for Gestational Diabetes (GDM) b. Note that the OGTT for GDM uses lower cut-offs: Fasting glucose ≥5.1 mmol/L, 2-hr glucose ≥8.5 mmol/L

Determine whether at risk / diabetic Diagnosis of diabetes mellitus in ASYMPTOMATIC adults (If elderly, frail and asymptomatic, please consider whether screening is appropriate.) Take together on separate day Determine whether at risk / diabetic (see fasting glucose & HbA1C ranges below) random glucose ≥11.1 mmol/L fasting glucose & HbA1C fasting glucose INITIAL lab glucose ≥7.0 mmol/L (Omit HbA1C if not suitable. See below.*) (random OR fasting) 7.8 – 11.0 mmol/L 6.1 – 6.9 mmol/L random glucose fasting suitable for HbA1C? * YES NO (repeat blood test on a separate day) HbA1C OGTT (75 g)

Determine whether at risk / diabetic Diagnosis of diabetes mellitus in ASYMPTOMATIC adults (If elderly, frail and asymptomatic, please consider whether screening is appropriate.) Take together on separate day Determine whether at risk / diabetic (see fasting glucose & HbA1C ranges below) random glucose ≥11.1 mmol/L fasting glucose & HbA1C fasting glucose INITIAL lab glucose ≥7.0 mmol/L (Omit HbA1C if not suitable. See below.*) (random OR fasting) 7.8 – 11.0 mmol/L 6.1 – 6.9 mmol/L random glucose fasting suitable for HbA1C? * YES NO (repeat blood test on a separate day) HbA1C OGTT (75 g) not diabetic not diabetic ≤41 mmol/mol fasting glucose ≤6.0 mmol/L AND 2-hr glucose ≤7.7 mmol/L

Determine whether at risk / diabetic Diagnosis of diabetes mellitus in ASYMPTOMATIC adults (If elderly, frail and asymptomatic, please consider whether screening is appropriate.) Take together on separate day Determine whether at risk / diabetic (see fasting glucose & HbA1C ranges below) random glucose ≥11.1 mmol/L fasting glucose & HbA1C fasting glucose INITIAL lab glucose ≥7.0 mmol/L (Omit HbA1C if not suitable. See below.*) (random OR fasting) 7.8 – 11.0 mmol/L 6.1 – 6.9 mmol/L random glucose fasting suitable for HbA1C? * YES NO (repeat blood test on a separate day) HbA1C OGTT (75 g) not diabetic at risk of DM not diabetic at risk of DM ≤41 mmol/mol 42 – 47 mmol/mol fasting glucose ≤6.0 6.1 – 6.9 (IFG) mmol/L AND OR 2-hr glucose ≤7.7 7.8 – 11.0 (IGT) mmol/L

Determine whether at risk / diabetic suitable for HbA1C? * YES NO HbA1C OGTT not diabetic at risk of DM diabetes ≥48 mmol/mol 42 – 47 ≤41 fasting glucose ≤6.0 2-hr mmol/L ≤7.7 AND OR 6.1 – 6.9 (IFG) 7.8 – 11.0 (IGT) ≥ 11.1 ≥ 7.0 Diagnosis of diabetes mellitus in ASYMPTOMATIC adults random ≥7.0 mmol/L ≥11.1 mmol/L INITIAL lab 7.8 – 11.0 mmol/L 6.1 – 6.9 mmol/L (repeat blood test on a separate day) Take together on separate day (random fasting) & HbA1C (Omit HbA1C if not suitable. See below.*) Determine whether at risk / diabetic (see fasting glucose & HbA1C ranges below) (75 g) (If elderly, frail and asymptomatic, please consider whether screening is appropriate.)

Determine whether at risk / diabetic suitable for HbA1C? * YES NO HbA1C OGTT not diabetic at risk of DM diabetes ≥48 mmol/mol 42 – 47 ≤41 fasting glucose ≤6.0 2-hr mmol/L ≤7.7 AND OR 6.1 – 6.9 (IFG) 7.8 – 11.0 (IGT) ≥ 11.1 ≥ 7.0 Diagnosis of diabetes mellitus in ASYMPTOMATIC adults random ≥7.0 mmol/L ≥11.1 mmol/L INITIAL lab 7.8 – 11.0 mmol/L 6.1 – 6.9 mmol/L (repeat blood test on a separate day) Take together on separate day (random fasting) & HbA1C (Omit HbA1C if not suitable. See below.*) Determine whether at risk / diabetic (see fasting glucose & HbA1C ranges below) (75 g) (If elderly, frail and asymptomatic, please consider whether screening is appropriate.) At risk of DM groups include: IFG = impaired fasting glucose IGT = impaired glucose tolerance HbA1C 42-47 mmol/mol Consider lifestyle advice & annual HbA1C check for these groups

Determine whether at risk / diabetic suitable for HbA1C? * YES NO HbA1C OGTT not diabetic at risk of DM diabetes ≥48 mmol/mol 42 – 47 ≤41 fasting glucose ≤6.0 2-hr mmol/L ≤7.7 AND OR 6.1 – 6.9 (IFG) 7.8 – 11.0 (IGT) ≥ 11.1 ≥ 7.0 Diagnosis of diabetes mellitus in ASYMPTOMATIC adults random ≥7.0 mmol/L ≥11.1 mmol/L INITIAL lab 7.8 – 11.0 mmol/L 6.1 – 6.9 mmol/L (repeat blood test on a separate day) Take together on separate day (random fasting) & HbA1C (Omit HbA1C if not suitable. See below.*) Determine whether at risk / diabetic (see fasting glucose & HbA1C ranges below) (75 g) (If elderly, frail and asymptomatic, please consider whether screening is appropriate.) Where there is diagnostic uncertainty consider contacting diabetes email advice service At risk of DM groups include: IFG = impaired fasting glucose IGT = impaired glucose tolerance HbA1C 42-47 mmol/mol Consider lifestyle advice & annual HbA1C check for these groups

New pathway Old pathway

New pathway Old pathway

New pathway Old pathway 1 2 3 1 2

GTT and HbA1c will pick up different individuals No single test is regarded as gold standard Physiological rise in HbA1c with age HbA1c more stable than glucose pre-analysis Less analytical variability in glucose assay than HbA1c Rapilose likely to be used as alternative to Lucozade Scottish Diabetes Group will issue national statement shortly on hypo treatment. Info also on DUK website

Trends in HbA1c & glucose testing for Lothian Yanhong Wang (SCI-Diabetes), Carol Thomson (Labs IT) Pilot of new pathway in 2015 Compared 6 months pre-pilot vs. 6 months pilot 15 GP practices in SE Edinburgh (~10% of all 1o care testing) Pilot study results: 2 x 6 month periods Pan-Lothian testing over same period Pre-pilot Pilot % change HbA1c 3,481 3,429 -1.5% Glucose 10,031 9,797 -2.3% OGTT 186 151 -18.8% 6 mth 2nd 6mth % change HbA1c 30,035 31,964 +6.4% Glucose 100,065 101,803 +1.7% Apparently neutral effect on HbA1c, glucose requesting (reassuring for lab) OGTT numbers small ?significant fall Feedback on use of pathway generally positive Post pilot… Pathway discussed with clinical leads for diabetes Distributed Lothian-wide as a recommendation in Oct 2016

HbA1c tests (per month) past 2 years Trends in HbA1c & glucose testing for Lothian Any change since introduction of pathway in Oct 2016? Oct ’16: new pathway starts * festive dip HbA1c tests (per month) past 2 years * Probably too early to draw any conclusions…. Jan’15 Jan’16 Oct Nov Dec % diagnostic HbA1c 31% 32% 40% Since Oct 2016, possible to distinguish HbA1c requested for diagnosis vs. monitoring: We will continue to follow these ratios over the coming year…

Trends in HbA1c & glucose testing for Lothian Long view: what is the trend in HbA1c requesting? HbA1c HbA1c + glucose Glucose HbA1c test numbers are rising… Glucose numbers are static/falling Both? Possible causes: - rising diabetic population (hence more HbA1c monitoring) - increasing use of HbA1c in diagnosis ± monitoring

18% increase over past 5 years No of HbA1c per diabetic popn Trends in HbA1c & glucose testing for Lothian NHS Lothian diabetic population 18% increase over past 5 years Ratio of HbA1c numbers : diabetic prevalence No of HbA1c per diabetic popn slight increase…

What to do when the results disagree Generally try to stick to one test (glucose or HbA1c) If you end up mixing and matching and they don’t agree: Take the more abnormal test and repeat that one If in doubt, Email your local hospital: RIE.DiabeticAdvice@nhslothian.scot.nhs.uk WGH.DiabeticAdvice@nhslothian.scot.nhs.uk WL.DiabeticAdvice@wlt.scot.nhs.uk

Questions?

Other local diagnostic guidelines… Lothian pathway is very similar to (independently drawn-up) guidelines in: Glasgow & Greater Clyde Lanarkshire Other pathways (some parts of England & Wales): HbA1c as 1st line test OR Risk scoring* as 1st line screening step, then HbA1c for high risk individuals (Can be conducted opportunistically by HCP or individual, or via electronic health record search.) *age, sex, ethnicity, fam hx of DM, waist size, BMI, HTN